India Cancer Treatment Drugs Market Outlook for 2023-28

Markntel Advisors has conducted a comprehensive study on the India Cancer Treatment Drugs Market is projected to grow at a CAGR of around 12.2% during the forecast period, i.e., 2023-28. With estimated 1.39 million cancer cases in 2020, the disease has become a public health concern in India. Earlier, the total number of deaths from cancer in India was more than 0.8 million in 2019. It is estimated that one woman dies of cervical cancer every 8 minutes in India due to cancer, according to the National Institute of Cancer Prevention and Research. Of every two women newly diagnosed with breast cancer, one dies of it in India. Moreover, tobacco consumption in the country is burgeoning, thereby mounting the total number of deaths from tobacco cancer.

In addition, the India Cancer Treatment Drugs Market Study highlights the impact of domestic and localized market players, emerging revenue opportunities, strategic market growth analysis, product approvals, product launches, geographic expansions, and technological innovations. The objective of the report is to provide a detailed understanding of the industry, including its features, factors, and elements, along with insights into the regulatory scenario & regional dynamics that may impact market growth. 

GET PDF SAMPLE REPORT- https://www.marknteladvisors.com/query/request-sample/india-cancer-treatment-market.html

Key Driver: Numerous Schemes Encouraging Affordable & Effective Cancer Diagnosis &Treatment

Cancer treatment has been one of the main focal areas of the Pradhan Mantri Jan Arogya Yojana in order to protect the beneficiaries from the catastrophic costs of cancer treatment. The delivery of services under the Ayushman Bharat Health and Wellness Centers (AB-HWCs) includes screening for three common malignancies, including oral, breast, and cervical cancers and other common non-communicable diseases.

Along similar lines, The National Pharmaceutical Pricing Authority (NPPA), which is part of the Ministry of Chemicals and Fertilizers, released a list of 390 non-scheduled anti-cancer medications in 2019 with MRP reductions of up to 87%. This action helped 22 lakh cancer patients in the nation and would save consumers about Rs. 800 crores annually. Following a decade of caution and organic growth, Indian pharmaceutical businesses are currently on an acquisition binge. And cancer medications seem to be their primary focus, thus driving the drug industry in the long run.

India Cancer Treatment Drugs Industry Breakdown: Key Revenue Generating Segments

To facilitate focused analysis, the India Cancer Treatment Drugs Market has been divided into different segments, providing shareholders with the opportunity to identify their areas of interest and the most profitable opportunities within the market. By incorporating technical trends, comprehensive analysis of the downstream & upstream value chain, as well as Porter's five forces analysis, we have diligently forecasted the industry landscape for specific regions/countries, presenting critical pointers for informed decision-making. The segments are as follows:

-By Treatment Type

-Chemotherapy

-Targeted Therapy

-Immunotherapy

-Hormonal Therapy

-Other Treatment Types

-By Drug Class

-Cytotoxic Drugs

-Targeted Drugs

-Hormonal Drugs

-Others

-By Type

-Blood Cancer

-Breast Cancer

-Colorectal Cancer

-Cervical Cancer

-Prostate Cancer

-Gastrointestinal Cancer

-Gynecologic Cancer

-Non-Hodgkin’s Cancer

-Respiratory/ Lung Cancer

-Stomach Cancer

-Other Cancers

-By End-Users

-Hospitals

-Specialty Clinics

-Cancer and Radiation Therapy Centers

-By Region

-North

-West

-South

-East

Each sections offer valuable insights into the India Cancer Treatment Drugs Market. The report includes essential pillars of the industry study, such as drivers, restraints, opportunities, and challenges. The report also provides information on industry overview, specifications, definitions, suppliers, R&D status, cost structure analysis, sources, and technological advancements, potential for improvement, applications, among others.

Get Full Report – https://www.marknteladvisors.com/research-library/india-cancer-treatment-market.html

Competitive Analysis of the India Cancer Treatment Drugs Industry

-Amgen

-Astellas Pharma Inc.

-AstraZeneca

-Bayer

-Bristol-Myers Squibb Company

-Cipla

-F. Hoffmann- La- Roche

-Merck KGaA

-Natco Pharma

-Novartis AG

-Pfizer

Request Customization of this report -https://www.marknteladvisors.com/query/request-customization/india-cancer-treatment-market.html

India Cancer Treatment Drugs Market Research Report Answers the Following Key Questions

  • How big is the India Cancer Treatment Drugs Market?
  • What is the projected growth rate or CAGR of the India Cancer Treatment Drugs Market during 2023-28?
  • What are the key trends or growth opportunities for the key players in the India Cancer Treatment Drugs Market?
  • Which ‘segment’ seems promising for companies operating in the India Cancer Treatment Drugs Market?

Note: Markntel Advisors provides personalized reports tailored to the specific needs and preferences of clients. For further information or inquiries regarding customized reports, please get in touch with the sales team, who will assist you in your purchase and address any queries you may have.

About Us

MarkNtel Advisors is a leading research, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.

Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.

Using such information, our clients can identify attractive investment opportunities & strategize their moves to yield higher ROI (Return of Interest) through an early mover advantage with top-management approaches.

We understand the mounting & diverse needs of our clients. Hence, our analysts focus on emerging industries to provide services that fulfil their assessment of the current & future industry potential, identify white spaces & hotspots, & venture into new geographies or business segments in the future.

Thank you for reading our report. If you have any further inquiries, kindly get in touch with us so that we may send you the most appropriate report.

Contact us today!

Email: sales@marknteladvisors.com

Phone: +1 628 895 8081 +91 120 4268433,

Address: 5214F Diamond Heights Blvd #3092,

San Francisco, CA 94131

United States